Navigation Links
Techne Corporation Releases Unaudited Second Quarter And Six Month Fiscal Year 2013 Results
Date:2/5/2013

rter of fiscal 2013.  The amount of the retroactive credit is approximately $975,000.

The Company's investment in ChemoCentryx, Inc. (CCXI) is included in short-term available for sale investments at December 31, 2012 at a fair-value of $69.1 million.  The Company's unrealized gain of $39.6 million on the investment, net of a deferred tax liability of $14.2 million, was included in accumulated other comprehensive income at December 31, 2012.

The Company did not repurchase any shares of its common stock during the quarter or six-month periods ended December 31, 2012.  Approximately $127 million remains available at December 31, 2012 for the repurchase and retirement of shares under the currently open authorization.

Forward Looking Statements:

Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements, including the expected effective tax rate, involve risks and uncertainties that may affect the actual results of operations. The following important factors, among others, have affected and, in the future, could affect the Company's actual results: the introduction and acceptance of new biotechnology and hematology products, the levels and particular directions of research by the Company's customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, the impact of currency exchange rate fluctuations, and the costs and results of research and product development efforts of the Company and of companies in which the Company has invested or with which it has formed strategic relationships.

For additional information concerning such factors, see the section titled "Risk Factors" in the Company's annual report on Form 10-K and quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission. We undertake no obligation to update or revise
'/>"/>

SOURCE Techne Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Techne Corporation Releases Unaudited Fourth Quarter And Fiscal Year 2012 Results
2. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
3. Luminex Corporation Reports Fourth Quarter And Full Year 2012 Results
4. NewLink Genetics Corporation Announces Exercise of Underwriters Option and Closing of Public Offering of Common Stock
5. MGC Diagnostics Corporation Appoints Wesley W. Winnekins as Executive Vice President, Finance and Corporate Development; Winnekins will also serve as Chief Financial Officer
6. Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
7. NewLink Genetics Corporation Announces Pricing of Public Offering of Common Stock
8. NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
9. CVS Caremark Corporation To Hold Fourth Quarter 2012 Conference Call
10. The law firms of Bernstein Litowitz Berger & Grossmann LLP and Labaton Sucharow LLP announce pendency of class action in In re Schering-Plough Corporation / ENHANCE Securities Litigation
11. MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... -- A decade-long JDRF-funded study led by the Institute ... Germany , is providing a deeper understanding of ... type 1 diabetes (T1D), highlighting the importance of pre-diabetes ... "Seroconversion to Multiple Islet Autoantibodies and Risk of Progression ... The Journal of the American Medical Association . ...
(Date:6/19/2013)... 19, 2013  Finesse Solutions, Inc, a manufacturer ... process applications, announced the launch of its new ... culture and fermentation.  The 3L glass vessels are ... Finesse bioreactors and are designed to optimize yield ... fully compatible with all Finesse G3Lab controllers, and ...
(Date:6/19/2013)... 19, 2013  Decision Resources, one of the ... and healthcare issues, finds that, for the treatment ... and European rheumatologists cite a therapy,s induction of ... influences their prescribing decisions. Over 60 percent and ... rank the percentage of patients achieving remission at ...
Breaking Medicine Technology:New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2
... 2011 Cell Therapeutics, Inc. ("CTI" or the "Company") ... results for the first quarter ended March 31, 2011. ... million through two financings, advanced pixantrone into a confirmatory ... Therapeutics Ltd. ("Chroma") to co-develop and market Chroma,s drug ...
... April 26, 2011 BD (Becton, Dickinson and Company) ... technology company, today reported quarterly revenues of $1.922 billion ... representing an increase of 6.8 percent from the prior-year ... percent, despite an unfavorable comparison to the prior year ...
Cached Medicine Technology:Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 2Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 3Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 4Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 5Cell Therapeutics, Inc. Reports First Quarter Accomplishments and Financial Results 6BD Announces Results for 2011 Second Fiscal Quarter 2BD Announces Results for 2011 Second Fiscal Quarter 3BD Announces Results for 2011 Second Fiscal Quarter 4BD Announces Results for 2011 Second Fiscal Quarter 5BD Announces Results for 2011 Second Fiscal Quarter 6BD Announces Results for 2011 Second Fiscal Quarter 7BD Announces Results for 2011 Second Fiscal Quarter 8BD Announces Results for 2011 Second Fiscal Quarter 9BD Announces Results for 2011 Second Fiscal Quarter 10BD Announces Results for 2011 Second Fiscal Quarter 11BD Announces Results for 2011 Second Fiscal Quarter 12BD Announces Results for 2011 Second Fiscal Quarter 13BD Announces Results for 2011 Second Fiscal Quarter 14
(Date:6/19/2013)... June 19 online edition of the journal Nature ... University of California, San Diego School of Medicine visually ... cardiac regeneration occurs in zebrafish after cardiac ventricular injury. ... in the heart are more plastic, or capable of ... More importantly, the research reveals a novel potential source ...
(Date:6/19/2013)... understanding of the genetic process that can lead to ... lesions for some women, and also raises a warning ... cases suggesting they could actually trigger the cancer ... a clearer picture of the chromosomal and genetic changes ... to chronic infection and, in less than 1 percent ...
(Date:6/19/2013)... significant disparities between minority and white clients in ... Moreover, these disparities vary widely from state to ... most states there,s something amiss," says Stephan Arndt, ... are strong racial and ethnic disparities for people ... programs successfully, and those disparities are something we ...
(Date:6/19/2013)... In early April, senior leaders from medical, law ... to discuss one question: how can first responders improve ... The preliminary results of this discussion are now available ... Hartford Consensus ," a concept paper published in the ... Trauma and Acute Care Surgery , official publication ...
(Date:6/19/2013)... Nearly 70 percent of Americans are on at ... take two, Mayo Clinic researchers say. Antibiotics, antidepressants ... study found. Twenty percent of patients are on ... findings, published online in the journal Mayo ... and video of Dr. Jennifer St. Sauver talking ...
Breaking Medicine News(10 mins):Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2Health News:Genetics of cervical cancer raise concern about antiviral therapy in some cases 2Health News:States vary widely on success rates for minorities in drug treatment programs 2Health News:States vary widely on success rates for minorities in drug treatment programs 3Health News:Hartford consensus aims to improve survival after mass shootings 2Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2
... science and progress of integrative medicine in the ... convene the "Summit on Integrative Medicine and the ... D.C. The summit will bring together distinguished researchers, ... the vision, challenges, evidence base, and opportunities for ...
... Control Weight Permanently , MIDLAND, Mich., Jan. 27 ... is the challenge. With this Health Enhancement Systems ... Healthy Weight for Life ( ... gain control of their weight -- and improve their health ...
... the fight against,oral cancer is now being offered by Barotz ... http://www.barotzdental.com , determines a,person,s risk for oral cancer disease in ... Americans are diagnosed with oral cancer each year. While,easy ... death rate,because it is routinely discovered late in its development," ...
... of the European Heart Rhythm Association (EHRA), is today ... More than 4,000 participants are expected to attend this ... and sudden cardiac death. , EHRA is a registered ... mission is to reduce the impact of cardiac arrhythmias ...
... Meanwhile, U.S. officials say illnesses linked to tainted peanut ... 27 (HealthDay News) -- The Georgia facility that produced ... nationwide salmonella outbreak has a history of health-inspection violations, ... officials reported Monday that the outbreak, which has now ...
... Forever" Solution , , DALLAS, Jan. 27 ... it,s swept under the rug as a nuisance. However, ... an indicator of a serious health problem called obstructive sleep ... of Plano is announcing a dental approach to end snoring ...
Cached Medicine News:Health News:IOM gathers health care leaders for summit on integrative medicine 2Health News:Thousands Look Better, Feel Better, and Have More Energy Because of NutriSum 2Health News:Barotz Dental Offers Free Online Oral Cancer Risk Assessment 2Health News:EUROPACE 2009 2Health News:Salmonella Outbreak Site Has History of Health Violations: Report 2Health News:Spouses of the Lone Star State Rejoice As Snoring Is DOA 2
For determination of triglycerides in serum or plasma. For Hitachi 704 / 911. Available with calibrator: Trucal U and also with controls: Trulab N, Trulab P, Trulab L....
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 1000 mg/dL (11.3 mmol/L). Single vial, dry powder reagent....
For the quantitative determination of triglycerides in serum. Linearity: 1000 mg/dl....
Alkaline phosphatase FS (IFCC). For determination of alkaline phosphatase (ALP) in serum or plasma. For Hitachi 717. Controls: Trulab N and Trulab P....
Medicine Products: